EGF and non-small cell lung carcinoma: In non-small lung cancer (NSCLC), also, Campbell et al. [95] showed that 100 ng/mL EGF induced a significant increase in invasiveness and this was blocked completely by 1 μM TTX or gefinitib (“Iressa”).